Gardner et al. showed that chemoresistance to cisplatin and etoposide in SCLC is partially due to the suppression of SLFN11, a protein with the role of inhibiting DNA replication and promoting cell death after DNA damage. Here, SLFN11 is linked to small cell lung carcinoma.